Back to Search
JAE KIM, M.D.
M.D.
Neurology Physician
NPI: 1841426400IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
58603(MN)ME175404(FL)10113(SD)
Radiology — Vascular & Interventional Radiology
Code: 2085R0204X
58603(MN)
Psychiatry & Neurology — Vascular Neurology
Code: 2084V0102X
58603(MN)10113(SD)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 2009
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.
PMID 39978685·J Allergy Clin Immunol·2025
8-other
Proportion of CD4CD49bLAG-3Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.
PMID 29890167·J Invest Dermatol·2018
8-other
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
PMID 30097359·Lancet·2018
3-trial
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
PMID 28927890·J Invest Dermatol·2018
3-trial
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
PMID 28423301·N Engl J Med·2017
3-trial
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
PMID 27686018·Annu Rev Med·2017
6-review
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
PMID 27185339·J Invest Dermatol·2016
4-observational
Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
PMID 26763436·J Invest Dermatol·2016
4-observational
Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions-Lessons Learned From Focus Groups.
PMID 27028481·JAMA Dermatol·2016
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 115 2nd Ave S Apt 1415
Minneapolis, MN 55401 - Phone
- (201) 952-0584
Locations (5)
Practice Location
115 2nd Ave S Apt 1415, Minneapolis, MN
(201) 952-0584
Practice Location
909 FULTON ST SE, MINNEAPOLIS, MN
(612) 672-7422
Practice Location
500 HARVARD ST SE, MINNEAPOLIS, MN
(612) 626-3343
Practice Location
2820 SE 3RD CT STE 200, OCALA, FL
(352) 401-8817
Practice Location
1210 W 18TH ST STE 100, SIOUX FALLS, SD
(605) 312-8500
Quick Facts
- NPI
- 1841426400
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 6
- Locations
- 5
- Years in Practice
- 17
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile